Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. - Wikidata - wikimedia - TriplyDB

Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.

Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.

http://www.wikidata.org/entity/Q39538754

about

In vivo bio-imaging using chlorotoxin-based conjugates Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion Co-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapy From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors Structure of a C-terminal AHNAK peptide in a 1:2:2 complex with S100A10 and an acetylated N-terminal peptide of annexin A2 Elemental analysis of scorpion venoms Bionanotechnology and the future of glioma.Progastrin Peptides Increase the Risk of Developing Colonic Tumors: Impact on Colonic Stem Cells A functional proteomic method for biomarker discovery.A Bioengineered Peptide that Localizes to and Illuminates Medulloblastoma: A New Tool with Potential for Fluorescence-Guided Surgical Resection Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates.Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies.Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy.Annexin A2 promotes glioma cell invasion and tumor progression Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy Thermal Decomposition Based Synthesis of Ag-In-S/ZnS Quantum Dots and Their Chlorotoxin-Modified Micelles for Brain Tumor Cell Targeting.Clathrin mediates endocytosis of progastrin and activates MAPKs: role of cell surface annexin A2.Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells Progastrin overexpression imparts tumorigenic/metastatic potential to embryonic epithelial cells: phenotypic differences between transformed and nontransformed stem cells.Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer.Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma Annexin A2 heterotetramer: structure and function 3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer.Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review.Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate.Monofunctional and higher-valent platinum anticancer agents.Agents that bind annexin A2 suppress ocular neovascularization.Venoms as a platform for human drugs: translating toxins into therapeutics.Advances in targeted therapeutic agents.The insecticidal potential of venom peptides.Nonclassically Secreted Regulators of Angiogenesis.Cystine-knot peptides: emerging tools for cancer imaging and therapy.Spider venomics: implications for drug discovery.The role of annexin A2 in tumorigenesis and cancer progression Chlorotoxin: Structure, activity, and potential uses in cancer therapy.Anti-gliomas Effect of Chlorotoxin-Conjugated Onconase at High Dose.Clathrin-mediated entry and cellular localization of chlorotoxin in human glioma.

P2860

Q24595399-C596F3DA-CD43-44B2-9422-3A857E0E5FC7 Q26830028-B7AB8B25-9355-4491-AA78-923C643ECDD4 Q27004631-784343AA-69DC-48CA-879E-79A1177F9159 Q27005742-4FDCB05B-89E9-4F44-9004-E192BBD873CB Q27326068-C4183F32-8358-47A7-ADCD-3C7B25412F90 Q27675650-375EF962-14CE-4CDD-8A73-125FC09C8C57 Q28821348-650DD72E-626F-4A35-BF40-BFD25C0A2B23 Q30417964-F1E91635-7506-49AD-ADC2-2AE5F086F5BF Q30424597-C6259750-C5F4-4AEA-AEE3-B4F48A801D0E Q30431185-57AD1255-B71F-40AE-81ED-5DAA72802E30 Q33914493-377D7C60-661B-4005-8643-E64F6D0DFC73 Q34066507-F64227A4-F952-44A0-85DC-5CDF19DCC86E Q34419939-5CB96D28-DE41-473C-8BBF-52B329801BBE Q34687047-9DEDADED-F2B5-4B82-BE83-682195F68B2E Q34917475-F6B68FB6-147D-46EF-9F19-828671EEF3C0 Q35448499-E37ECF58-6D74-47C9-B29A-08FEF1E4E4E8 Q35575328-5572EEB2-C6E6-4F4E-B057-2013706F37D3 Q35900465-69EBE719-CBC1-485D-A7BA-2AF69BFB31F6 Q35900882-A31C6C21-06E8-43C2-9D4B-5AD03D394DC6 Q35953911-74D7B2DA-A9E8-4213-927B-A7A1B39BE938 Q36131172-DA6B6A54-68BF-462D-A9A3-869B5686D033 Q36175192-40D651D4-2682-48DF-9100-1398E0C176BD Q36347121-7692E1B7-A39E-468D-A740-3CFE084D6A8A Q36470507-E1F3BF5D-B9A5-425F-9D31-0EC678DB7922 Q36790362-7B347D08-DD4D-4CFA-8454-DF4BDF3FAD78 Q36798100-2A9F219A-655C-45FA-A4B5-AB849F3F27CF Q37026387-0A9FBA51-45A8-4C95-871A-4024D55F983C Q37150006-9D6A1BC1-F70E-4CBD-968C-3A24536EBB91 Q37282213-387D7958-97AA-4894-9EAD-387A922DFA2D Q37734451-5DBDABBB-26D3-4AFC-BB10-26A85060CE56 Q37937049-44E40129-CEF4-438F-A2CF-4A73BBC9F5A4 Q38029122-771F8527-65B0-4C50-83E9-19FA3FB11AF1 Q38092679-C0B9B4BB-E181-4C30-817D-D45F27D09997 Q38186720-98D886E3-C532-40E6-B5AB-FD7C996E80C6 Q38243927-8846FE77-53A3-4131-BDF8-319B418F0F8E Q38269167-4B9998B0-8BA0-44D7-86EE-58A9104BCED5 Q38366258-D18AE6CB-AE59-4A5A-905E-E0ED1128FD0B Q38595154-87A7EDB3-3417-40EF-A927-567ACCDE9FC1 Q38761274-F2AC81A3-B411-4109-AFB3-313DF876C605 Q38868574-E3A2859A-211E-433A-9007-DA7D07EA7141

P2860

Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.

http://www.wikidata.org/entity/Q39538754

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Annexin A2 is a molecular targ ...... g and anti-angiogenic effects.

@en

Annexin A2 is a molecular targ ...... g and anti-angiogenic effects.

@nl

type

label

Annexin A2 is a molecular targ ...... g and anti-angiogenic effects.

@en

Annexin A2 is a molecular targ ...... g and anti-angiogenic effects.

@nl

prefLabel

Annexin A2 is a molecular targ ...... g and anti-angiogenic effects.

@en

Annexin A2 is a molecular targ ...... g and anti-angiogenic effects.

@nl

P1433

Q39538754-F710DDC6-B3ED-482A-9825-1EFFAD829084

P1476

Q39538754-2F613725-C931-43A6-9244-40E3C85CF12C

P2093

Q39538754-1F09D6A2-A807-42EC-A7EE-4228BB791F73

Q39538754-41ADA97C-E873-4F8B-BC00-2AC19F43761C

Q39538754-43107B54-B69E-4961-A9F7-0F1D15676B99

Q39538754-61A0A94B-C5D8-4B13-97D5-28FE73BBEEAC

Q39538754-90EE19BC-DA29-4AB2-841B-0843E3856B02

Q39538754-C66A7ECE-C510-4BC8-BB30-BC056D51A491

Q39538754-CBC670D8-2D15-4D13-92F4-F343E93E1144

P2860

Q39538754-00011E76-49AD-451F-82F1-8BE38D8C75AE

Q39538754-1F78A4FF-EA00-47B0-AECC-9AE302A6906F

Q39538754-2BAFF848-BA47-4490-982B-76D7B1368414

Q39538754-362679CC-4EC4-4768-85B9-B8996DEA9012

Q39538754-39E8CA36-597C-44C2-B010-F2FA9081FA1C

Q39538754-4143CA86-DE1F-4706-923D-8E7D614C796E

Q39538754-43B86A67-94BB-44F1-9A7B-170222BD3D28

Q39538754-466043DB-374E-4925-9E32-49C011694AF2

Q39538754-46CAE759-C348-477F-B2B0-1580E19A2240

Q39538754-51411B2F-942C-4291-B9E5-234385592D07

P304

Q39538754-E646F3A7-E06D-4C60-8992-95D01333F6C6

P31

Q39538754-ACCCFB2D-C475-4715-A5D0-DBA479994F39

P356

Q39538754-5F39A555-6073-4999-9F06-CBC4894860B6

P407

Q39538754-9BF33EBA-3101-4DD3-AEEC-C439C5069D1A

P433

Q39538754-81BC9BCD-72BE-40CD-B520-9E5FB7712BCE

P478

Q39538754-977C82A6-2A27-4627-9BD4-AB5C15B8A551

P50

Q39538754-2C3AF46F-73A7-4740-A723-4AA6793FF0DF

P577

Q39538754-34DA4028-25FB-4F41-8192-178D60A28CAC

P698

Q39538754-D574D3CE-4EA1-4D61-B862-6834ED10E427

P932

Q39538754-421214D3-F1DD-44B2-90F2-D3A36CD6A31B

P356

JBC.M109.066092

P1433

Journal of Biological Chemistry

P1476

Annexin A2 is a molecular targ ...... g and anti-angiogenic effects.

@en

P2093

Douglas B Jacoby

http://www.w3.org/2001/XMLSchema#string

Eric W Johnson

http://www.w3.org/2001/XMLSchema#string

John M Asara

http://www.w3.org/2001/XMLSchema#string

Judson Ratliff

http://www.w3.org/2001/XMLSchema#string

Kamala Kesavan

http://www.w3.org/2001/XMLSchema#string

Preeti Misra

http://www.w3.org/2001/XMLSchema#string

William Dahlberg

http://www.w3.org/2001/XMLSchema#string

P2860

PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor

Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo

Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin

Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2

Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci

Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma

Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion

Tissue plasminogen activator is a potent activator of PDGF-CC

Molecular classification and survival prediction in human gliomas based on proteome analysis.

PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment.

P304

4366-4374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M109.066092

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P50

John V Frangioni

P577

2009-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20018898

http://www.w3.org/2001/XMLSchema#string

P932

2836041

http://www.w3.org/2001/XMLSchema#string